OsteoDex
Cancer (Prostate Cancer, Multiple Myeloma)
Phase 2Active
Key Facts
About DexTech Medical
DexTech Medical is a clinical-stage biotech developing targeted cancer therapies using its proprietary GuaDex platform, a carbohydrate-drug-conjugate technology. The company's pipeline includes several drug candidates, most notably OsteoDex for prostate cancer, which appears to be in advanced clinical studies. With a lean operational model, patented technology, and a focus on urological oncology, DexTech aims to address significant unmet medical needs in cancer treatment, though it faces the typical high-risk, high-cost challenges of drug development.
View full company profile